Plasminogen activator
From Proteopedia
(Difference between revisions)
| Line 8: | Line 8: | ||
Updated on {{REVISIONDAY2}}-{{MONTHNAME|{{REVISIONMONTH}}}}-{{REVISIONYEAR}} | Updated on {{REVISIONDAY2}}-{{MONTHNAME|{{REVISIONMONTH}}}}-{{REVISIONYEAR}} | ||
| + | {{#tree:id=OrganizedByTopic|openlevels=0| | ||
| - | [[1a5i]] – PLA residues 213-477 + EGR-CMK – Vampire bat<br /> | + | *Plasminogen activator |
| - | + | ||
| + | **[[1a5i]] – PLA residues 213-477 + EGR-CMK – Vampire bat<br /> | ||
| + | **[1bqy]] – PLA – Pit viper | ||
| - | + | *Tissue plasminogen activator | |
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | [[ | + | **[[1a5h]] – hTPA HC+LC + benzamidine – human<br /> |
| + | **[[1rtf]] - hTPA HC+LC<br /> | ||
| + | **[[1tpg]] – hTPA F1-G - NMR<br /> | ||
| + | **[[1bda]] – hTPA catalytic domain (mutant) + EGR-CMK<br /> | ||
| + | **[[1pk2]] – hTPA kringle 2 domain + 6-aminohexanoic acid – NMR<br /> | ||
| + | **[[1tpk]], [[1pml]] - hTPA kringle 2 domain<br /> | ||
| + | **[[1kdu]] - hTPA kringle domain – NMR<br /> | ||
| + | **[[1tpm]], [[1tpn]] - hTPA fibrin-binding domain – NMR | ||
| + | *Urokinase-type plasminogen activator see [[Urokinase]] | ||
| + | }} | ||
[[Category:Topic Page]] | [[Category:Topic Page]] | ||
Revision as of 11:44, 3 December 2014
Plasminogen activator (PLA) is a serine protease which converts plasminogen to plasmin. It includes Tissue PLA (TPA) which is involved in breakdown of blood clots and urokinase-type PLA Urokinase. TPA structure contains heavy and light chains (HC, LC). PLA is inhibited by PLA inhibitor 1 and 2.
3D structures of plasminogen activator
Updated on 03-December-2014
